semaglutide 2.65 mg Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes Semaglutide 0.25mg 0.5mg 1mg |

The useful move is to pick those patients up with simple noninvasive tests, rather than waiting on a separate liver workup to confirm an eligibility that, for most of them, is already there

Journal of Clinical Endocrinology & Metabolism, 106 (3), 650-663

Ozempic may be more accessible for diabetic patients, while Wegovy provides clearer weight loss indication for non-diabetic individuals

These include nausea, vomiting, stomach pain, headache, tiredness, constipation, diarrhea, heartburn and more

When managing type 2 diabetes or weight loss, choosing the right medication is crucial for optimal outcomes

February 2026 On February 23, 2026, the Hon